Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 54Leukemia 18Lymphoma 13Lymphoma, Extranodal NK-T-Cell 8Burkitt Lymphoma 8Recurrence 5Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Acute 5Leukemia, Biphenotypic, Acute 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm, Residual 3Dendritic Cell Sarcoma, Interdigitating 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Prolymphocytic 1Leukemia, Erythroblastic, Acute 1Hypersensitivity 1Hematologic Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Ataxia Telangiectasia 1Ataxia 1

Interventions

Cytarabine 34Busulfan 17Cyclophosphamide 16fludarabine phosphate 15Peripheral Blood Stem Cell Transplantation 13Filgrastim 13Etoposide 13Idarubicin 12Mitoxantrone 9Cyclosporine 9Antilymphocyte Serum 9Methotrexate 8Daunorubicin 8Whole-Body Irradiation 6Radiotherapy 6Tacrolimus 5Cord Blood Stem Cell Transplantation 5Clofarabine 5Mycophenolic Acid 4Methylprednisolone 4Melphalan 4Gemtuzumab 4Flow Cytometry 4Arsenic Trioxide 4aldesleukin 3Topotecan 3Imatinib Mesylate 3Cytogenetic Analysis 3Cyclosporins 3Bortezomib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Erythroblastic, Acute × Asparaginase × Clear all
NCT00136084 2012-12-05

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

St. Jude Children's Research Hospital

Phase 3 Completed
238 enrolled 13 charts
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡